Key statistics
On Monday, Terns Pharmaceuticals Inc (TERN:NSQ) closed at 37.98, -21.30% below its 52-week high of 48.26, set on Dec 10, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 39.42 |
|---|---|
| High | 39.50 |
| Low | 36.19 |
| Bid | 35.00 |
| Offer | 39.98 |
| Previous close | 37.77 |
| Average volume | 2.26m |
|---|---|
| Shares outstanding | 106.20m |
| Free float | 105.56m |
| P/E (TTM) | -- |
| Market cap | 4.03bn USD |
| EPS (TTM) | -1.03 USD |
Data delayed at least 15 minutes, as of Feb 09 2026 21:00 GMT.
More ▼
Announcements
- Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
- Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference
- Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
- Terns Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
- Terns Announces Pricing of Upsized $650 Million Public Offering
- Terns Announces Proposed Public Offering
- Terns Highlights Additional Positive Phase 1 Clinical Data Supporting TERN-701’s Best-in-Disease Potential in Relapsed/Refractory CML at the 67th ASH Annual Meeting
- Terns Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in London
- Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
- Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
More ▼
